Skip to content

Dietary Supplementation With Blueberry in OA

Highbush Blueberry Supplementation for Osteoarthritis Pain, Intra-articular Inflammation and Post-operative Recovery in Total Knee Replacement Patients

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05784545
Enrollment
58
Registered
2023-03-27
Start date
2023-05-22
Completion date
2027-09-01
Last updated
2025-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis

Brief summary

Osteoarthritis is a painful long term joint condition that is associated with poor quality of life. There are no treatments to prevent it. Inflammation is one cause of osteoarthritis. This inflammation is complex. It involves many joint tissues, like cartilage and fat. It also involves many proteins that act as inflammatory 'signals'. Safely targeting these proteins with medications has so far proved ineffective. Physiotherapy and weight loss can help osteoarthritis, but there is a need for other approaches. Blueberries are rich in natural chemicals called polyphenols; these have well-established anti-inflammatory effects. Blueberries and other fruits may improve osteoarthritis symptoms, but the investigators do not know how this improvement happens. It may be that these foods reduce inflammation within the joint tissues. They will investigate this. This will help us to understand 1) how blueberries improve osteoarthritis symptoms and 2) whether dietary supplementation with blueberries could slow down joint damage in osteoarthritis, rather than just improving symptoms. Additionally, high levels of joint inflammation predict poorer recovery from joint replacement surgery. Therefore, blueberry supplementation may hasten this recovery. Fifty eight people scheduled to have a knee replacement for osteoarthritis will receive either six weeks blueberry supplementation or a placebo pre-surgery. Participants will continue the supplementation for six weeks after surgery. First, this study will use tissue samples (cartilage, fat and the joint lining called synovium) obtained during surgery to investigate the effects of pre-operative blueberry supplementation on markers of joint inflammation. Second, this study will assess the ability of dietary supplementation with blueberries to improve the symptoms of osteoarthritis. Finally, this study will investigate the effect of blueberry supplementation on recovery from total knee replacement. Our investigations may provide evidence to support dietary supplementation with blueberries to slow down osteoarthritis progression and to improve recovery from osteoarthritis joint replacement surgery.

Interventions

DIETARY_SUPPLEMENTBlueberry powder supplement

The intervention in this study is 12 weeks of daily blueberry supplementation which is comprised of freeze-dried powdered whole blueberries i.e., blueberries with water removed.

The intervention in this study is 12 weeks of daily maltodextrin supplement used to mimic the carbohydrate composition of whole blueberries.

Sponsors

U.S. Highbush Blueberry Council
CollaboratorOTHER
Royal Devon and Exeter NHS Foundation Trust
CollaboratorOTHER
University of Exeter
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Participants capable of giving informed consent * Sex: Male and female * Age: \> 40 years - Those under 40 are more likely to have an undiagnosed secondary cause of osteoarthritis * BMI: \> 18 kg/m2 * Listed to have a total knee replacement for osteoarthritis * Participants are permitted to participate in other ongoing surgical intervention studies, as long as these are not trials of a dietary supplement or a medication.

Exclusion criteria

* Those who have received intravenous or oral immunosuppressant medications in past 2 years * Those who have had intra-articular steroid injection in 6 months preceding surgery. * Some secondary causes of osteoarthritis (mechanistic confounders that are likely to influence tissue inflammation measures: * Known congenital joint disorders * Other inflammatory arthritis e.g. rheumatoid arthritis * Avascular necrosis, infectious arthritis * Paget disease * Osteopetrosis * Osteochondritis dissecans * Hemochromatosis * Wilson's disease * Hemoglobinopathy * Ehlers-Danlos syndrome * Marfan syndrome * Acromegaly * Those typically consuming more than eight 80 g portions (or juice equivalent) of blueberries, blackberries, strawberries, raspberries, blackcurrants, pomegranate or cherries per week * Those with a known fruit allergy, for which they carry an adrenaline auto-injector or have required anti-histamine, adrenaline, glucocorticoid or beta-agonist treatment. * Those who cannot adequately understand verbal explanations or written information given in English

Design outcomes

Primary

MeasureTime frameDescription
Concentration of TNF-ALPHA gene expression in joint tissue (synovium, infrapatellar adipose tissue and cartilage)In knee at time of surgery (when replaced)Inflammatory protein

Secondary

MeasureTime frameDescription
Concentration of broad panel of Inflammatory and pro-cartilage cytokines samplesBaseline and pre-operativelyUsing multiplex immunoassay including but not limited to at TNFα, IL-6, IL-10 and IL-1β, MIP1α, Galectin 1, Chemerin, Eotaxin, gp130, MCP-1, IL-7, MIP3α, IL-15, Aggrecan, Resistin, Leptin, MIP1β, MMP-1, MMP-3 and MMP-13
Concentration of broad panel of Inflammatory and pro-cartilage degradative gene and protein expression markersIn knee at time of surgery (when replaced)Using RTqPCR and immunoblotting including but not limited to TNFα, IL-6, IL1β, IL-8, IL-10, IL-18, IL-7, IL-15, MCP1, LEP, ADIPOQ, NAMPT, RETN, TGFB1, MMP1, MMP2, MMP3, MMP9, MMP13, TIMP1, TIMP2, TIMP3, TIMP4, ADAMTS4, ADAMTS5, , ACAN, COL1A1, COL2A1, COL13A1, COL14A1, COL15A1, DKK1, CCL2, CCL3, CCL4, CCL5, CCL7, CCL8, CCL11, CCL20, CX3CL1, CCR3, CCR2, LGALS1, RARRES2, and IL6ST
Western Ontario and McMaster Universities Arthritis Index ScoreBaseline, week 3, week 6, post-surgery, weeks 7, 9 and 12Validated questionnaire (0-96 where a higher score is worse)

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026